Atai Life Sciences Share Holder Equity 2020-2023 | ATAI
Atai Life Sciences share holder equity from 2020 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
| Atai Life Sciences Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $244 |
| 2022 | $266 |
| 2021 | $386 |
| 2020 | $95 |
| 2019 | $60 |
| Atai Life Sciences Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023-12-31 | $244 |
| 2023-09-30 | $269 |
| 2023-06-30 | $216 |
| 2023-03-31 | $241 |
| 2022-12-31 | $266 |
| 2022-09-30 | $296 |
| 2022-06-30 | $320 |
| 2022-03-31 | $354 |
| 2021-12-31 | $386 |
| 2021-09-30 | $463 |
| 2021-06-30 | $485 |
| 2021-03-31 | $120 |
| 2020-12-31 | $95 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.343B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $17.269B | 10.45 |
| Quest Diagnostics (DGX) | United States | $15.262B | 15.77 |
| DaVita (DVA) | United States | $11.791B | 14.65 |
| Chemed (CHE) | United States | $8.503B | 26.36 |
| Encompass Health (EHC) | United States | $8.378B | 21.45 |
| Elanco Animal Health (ELAN) | United States | $6.685B | 15.20 |
| Option Care Health (OPCH) | United States | $5.181B | 19.61 |
| RadNet (RDNT) | United States | $3.783B | 102.40 |
| Amedisys (AMED) | United States | $3.009B | 21.32 |
| LifeStance Health (LFST) | United States | $2.546B | 0.00 |
| Astrana Health (ASTH) | United States | $2.099B | 26.20 |
| Addus HomeCare (ADUS) | United States | $1.608B | 24.43 |
| U.S Physical Therapy (USPH) | United States | $1.585B | 41.09 |
| Pennant (PNTG) | United States | $0.642B | 37.54 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.448B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.026B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.019B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.011B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |